Literature DB >> 1944235

Distinct pathways of desensitization of A1- and A2-adenosine receptors in DDT1 MF-2 cells.

V Ramkumar1, M E Olah, K A Jacobson, G L Stiles.   

Abstract

Desensitization of adenosine receptors (ARs) was studied in DDT1 MF-2 cells, which possess both A1- and A2AR, differentially coupled to adenylate cyclase. (-)-N6-(R)-Phenylisopropyladenosine (R-PIA), an A1AR-selective agonist at the appropriate concentrations, desensitized A1AR-mediated inhibition of adenylate cyclase activity in a time- (t1/2, 8 hr) and dose-dependent and reversible fashion. This was associated with significant decreases in total A1AR number and in the number of receptors possessing a high affinity for agonist in membrane preparations. The decrease in total A1AR in the membranes from the desensitized cells (approximately 40%) was associated with a 37% increase in A1AR measured in light vesicle preparations, compared with control cells. To test a possible role of phosphorylation in A1AR desensitization, cells were incubated with [32P]orthophosphate, followed by exposure to R-PIA for 18 hr. Subsequent purification of the A1AR indicated a 3-4-fold increase in phosphorylation of A1AR in cells treated with R-PIA, compared with control cells. Desensitization of the A1AR did not alter the levels of alpha s and alpha 12 proteins or affect the ability of stimulatory effectors, such as isoproterenol, sodium fluoride, and forskolin, to activate adenylate cyclase. These results suggest that uncoupling, down-regulation, and phosphorylation of the A1AR contribute, at least in part, to desensitization of this inhibitory receptor. Desensitization of the A2AR was characterized using an A2-selective agonist, 2-[4-(2-(4-aminophenyl]methylcarbonyl)ethyl)phenyl]ethylamino- 5'-N-ethylcarboxamidoadenosine (PAPA-APEC). Pretreatment of cells with PAPA-APEC (100 nM) resulted in a rapid loss of agonist stimulation of adenylate cyclase activity (t1/2 of this effect, 45 min). This effect was dose dependent (EC50, approximately 10 nM) and rapidly reversible. Interestingly, desensitization of the A2AR resulted in no change in receptor number, affinity, or mobility on sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Taken together, these data suggest distinct mechanisms of desensitization of A1- and A2ARs in a single cell type.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1944235      PMCID: PMC5602552     

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  35 in total

1.  Adenosine receptors and beyond: molecular mechanisms of physiological regulation.

Authors:  G L Stiles
Journal:  Clin Res       Date:  1990-01

2.  In vivo pertussis toxin administration: effects on the function and levels of Gi alpha proteins and their messenger ribonucleic acids.

Authors:  V Ramkumar; G L Stiles
Journal:  Endocrinology       Date:  1990-02       Impact factor: 4.736

3.  On the mechanism of activation of muscarinic K+ channels by adenosine in isolated atrial cells: involvement of GTP-binding proteins.

Authors:  Y Kurachi; T Nakajima; T Sugimoto
Journal:  Pflugers Arch       Date:  1986-09       Impact factor: 3.657

4.  Phosphorylation of chick heart muscarinic cholinergic receptors by the beta-adrenergic receptor kinase.

Authors:  M M Kwatra; J L Benovic; M G Caron; R J Lefkowitz; M M Hosey
Journal:  Biochemistry       Date:  1989-05-30       Impact factor: 3.162

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Regulation of GH3-cell function via adenosine A1 receptors. Inhibition of prolactin release, cyclic AMP production and inositol phosphate generation.

Authors:  T M Delahunty; M J Cronin; J Linden
Journal:  Biochem J       Date:  1988-10-01       Impact factor: 3.857

7.  Purification of A1 adenosine receptor from rat brain membranes.

Authors:  H Nakata
Journal:  J Biol Chem       Date:  1989-10-05       Impact factor: 5.157

8.  Modification of the rat adipocyte A1 adenosine receptor-adenylate cyclase system during chronic exposure to an A1 adenosine receptor agonist: alterations in the quantity of GS alpha and Gi alpha are not associated with changes in their mRNAs.

Authors:  J P Longabaugh; J Didsbury; A Spiegel; G L Stiles
Journal:  Mol Pharmacol       Date:  1989-11       Impact factor: 4.436

9.  Reciprocal modulation of agonist and antagonist binding to A1 adenosine receptors by guanine nucleotides is mediated via a pertussis toxin-sensitive G protein.

Authors:  V Ramkumar; G L Stiles
Journal:  J Pharmacol Exp Ther       Date:  1988-09       Impact factor: 4.030

10.  Heterologous desensitization of the inhibitory A1 adenosine receptor-adenylate cyclase system in rat adipocytes. Regulation of both Ns and Ni.

Authors:  W J Parsons; G L Stiles
Journal:  J Biol Chem       Date:  1987-01-15       Impact factor: 5.157

View more
  36 in total

1.  Pharmacological characterization of adenosine receptors in PGT-beta mouse pineal gland tumour cells.

Authors:  B C Suh; T D Kim; J U Lee; J K Seong; K T Kim
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

2.  E. coli lipopolysaccharide attenuates adenosine A(1) receptor-mediated increase in plasma exudation from the hamster cheek pouch.

Authors:  Xiao-pei Gao; Israel Rubinstein
Journal:  Inflamm Res       Date:  2010-10-06       Impact factor: 4.575

3.  Immunological identification of A2 adenosine receptors by two antipeptide antibody preparations.

Authors:  T M Palmer; K A Jacobson; G L Stiles
Journal:  Mol Pharmacol       Date:  1992-09       Impact factor: 4.436

4.  Adenosine A1-receptor stimulation of inositol phospholipid hydrolysis and calcium mobilisation in DDT1 MF-2 cells.

Authors:  T E White; J M Dickenson; S P Alexander; S J Hill
Journal:  Br J Pharmacol       Date:  1992-05       Impact factor: 8.739

5.  When to re-dose regadenoson?

Authors:  Gregory S Thomas; Aaron F Jolly; Michael Safani
Journal:  J Nucl Cardiol       Date:  2015-12-29       Impact factor: 5.952

6.  Chemical modification and irreversible inhibition of striatal A2a adenosine receptors.

Authors:  K A Jacobson; G L Stiles; X D Ji
Journal:  Mol Pharmacol       Date:  1992-07       Impact factor: 4.436

7.  Adenosine receptor-mediated modulation of acetylcholine release from rat striatal synaptosomes.

Authors:  K A Kirkpatrick; P J Richardson
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

8.  The effect of calcium removal on the suppression by adenosine of epileptiform activity in the hippocampus: demonstration of desensitization.

Authors:  H Hosseinzadeh; T W Stone
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

9.  Ischaemia/reperfusion selectively attenuates coronary vasodilatation to an adenosine A2- but not to an A1-agonist in the dog.

Authors:  B F Cox; B D Greenland; M H Perrone; L A Merkel
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

10.  Adenosine mediated desensitization of cAMP signaling enhances T-cell responses.

Authors:  Ailian Yang; Ashley D Mucsi; Melanie D Desrosiers; Jiang-Fan Chen; Jürgen B Schnermann; Michael R Blackburn; Yan Shi
Journal:  Eur J Immunol       Date:  2010-02       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.